vtx958
vtx958: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ventyx Biosciences, Inc. (VTYX) | Phase 2 |
Clinical Trials (1)
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's Disease
Frequently asked questions
Who is developing vtx958?
vtx958 is being developed by Ventyx Biosciences, Inc..
How many clinical trials involve vtx958?
BioSniper tracks 1 clinical trial involving vtx958.
Get deeper analysis on vtx958
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis